<?xml version="1.0" encoding="UTF-8"?>
<p>Since then, considerable work has expanded knowledge on this phenomenon referred to as antibody-dependent enhancement (ADE); described as 
 <italic>cross-reactive IgG antibodies from a previous infection with poor neutralizing capability which bind the heterologous serotype and enhances its uptake</italic> via 
 <italic>FcRâ€™s into host cells</italic> [
 <xref rid="B51-vaccines-07-00203" ref-type="bibr">51</xref>,
 <xref rid="B64-vaccines-07-00203" ref-type="bibr">64</xref>]. This is likely a mediator of increased viremia mediated through increased host cell infection [
 <xref rid="B64-vaccines-07-00203" ref-type="bibr">64</xref>].
</p>
